{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:38:50Z","timestamp":1776818330056,"version":"3.51.2"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.brachy.2025.12.011","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T12:32:52Z","timestamp":1772022772000},"page":"432-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Point S (sigmoid) doses and correlation with late recto-sigmoid adverse events in patients undergoing image-based brachytherapy for cervical cancer: clinical outcomes"],"prefix":"10.1016","volume":"25","author":[{"given":"Prachi","family":"Mittal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1945-1648","authenticated-orcid":false,"given":"J.","family":"Kamalnath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayuri","family":"Charnalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7736-9804","authenticated-orcid":false,"given":"A.K.","family":"Anjana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeevanshu","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supriya","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2025.12.011_bib0001","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2025.12.011_bib0002","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.radonc.2016.06.006","article-title":"Dose\u2013volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: results from the prospective multicenter EMBRACE study","volume":"120","author":"Mazeron","year":"2016","journal-title":"Radiotherapy Oncol"},{"key":"10.1016\/j.brachy.2025.12.011_bib0003","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.ijrobp.2013.11.214","article-title":"Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer: results from a prospective study","volume":"88","author":"Chopra","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.12.011_bib0004","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ijrobp.2021.09.055","article-title":"Severity and persistency of late gastrointestinal morbidity in locally advanced cervical cancer: lessons learned from EMBRACE-I and implications for the future","volume":"112","author":"Spampinato","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.12.011_bib0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.radonc.2013.01.011","article-title":"Inter-application variation of dose and spatial location of D2cm3 volumes of OARs during MR image based cervix brachytherapy","volume":"107","author":"Jamema","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2025.12.011_bib0006","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.brachy.2023.01.003","article-title":"Sigmoid dose accumulation and reporting for multifractionated brachytherapy for cervical cancer: methodological development of sigmoid points through virtual endoscopic method","volume":"22","author":"Bindal","year":"2023","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2025.12.011_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055765","article-title":"Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial","volume":"12","author":"Chopra","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.brachy.2025.12.011_bib0008","unstructured":"https:\/\/www.embracestudy.dk\/UserUpload\/PublicDocuments\/EMBRACE%20II%20Protocol.pdf accessed on\u202f21st\u202fDecember\u202f2025."},{"key":"10.1016\/j.brachy.2025.12.011_bib0009","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4103\/0973-1482.87027","article-title":"Additional rectal and sigmoid mucosal points and doses in high dose rate intracavitary brachytherapy for carcinoma cervix: a dosimetric study","volume":"7","author":"Mahantshetty","year":"2011","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.brachy.2025.12.011_bib0010","unstructured":"https:\/\/www.clinicaltrials.gov\/study\/NCT07164534?cond=cervix&term=supriya%20&rank=5 accessed on 21st December 2025."}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125003940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125003940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T23:43:30Z","timestamp":1776815010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472125003940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1538472125003940"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2025.12.011","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Point S (sigmoid) doses and correlation with late recto-sigmoid adverse events in patients undergoing image-based brachytherapy for cervical cancer: clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2025.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}